| Age, mean (SD) |
42.2 (8.6) |
|
| Female, N (%) |
31 (58.5) |
|
| Education, years, mean (SD) |
14.2 (2.3) |
|
| Estimated years to symptom onset mean (SD) |
-2.8 (5.3) |
|
| APOE genotype, N (%) |
|
| 23 |
3 (5.7) |
| 24 |
2 (3.8) |
| 33 |
31 (58.4) |
| 34 |
15 (28.3) |
| 44 |
2 (3.8) |
|
| MMSE: Baseline mean (SD), |
28.0 (2.3) |
| Scale range |
0 - 30 |
|
| MMSE: 3-year change from baseline mean (SD) |
-4.5 (4.9) |
|
| WORDDEL: Baseline mean (SD) |
1.9 (2.0) |
| Scale range |
0 - 16 |
|
| WORDDEL: 3-year change from baseline mean (SD) |
-0.8 (1.1) |
|
| PAPER: Baseline mean (SD) |
5.9 (2.8) |
| Scale range |
0 - 12 |
|
| PAPER: 3-year change from baseline mean (SD) |
-1.1 (1.5) |
|
| WAIS DIGSYM: Baseline mean (SD) |
53.3 (15.2) |
| Scale range |
0 - 93 |
|
| WAIS DIGSYM: 3 year change from baseline mean (SD) |
-4.0 (11.3) |
|
| PAIRBINDING: Baseline mean (SD) |
9.8 (2.7) |
| Scale range |
0 - 12 |
|
| PAIRBINDING: 3 year change from baseline mean (SD) |
-0.5 (3.3) |
|
| BOSTON: Baseline mean (SD) |
26.4 (3.2) |
| Scale range |
0 - 30 |
|
| BOSTON: 3 year change from baseline mean (SD) |
-1.5 (5.2) |
